0000000000610384

AUTHOR

Jens Wohlmann

showing 2 related works from this author

Zebrafish Embryos Allow Prediction of Nanoparticle Circulation Times in Mice and Facilitate Quantification of Nanoparticle–Cell Interactions

2020

The zebrafish embryo is a vertebrate well suited for visualizing nanoparticles at high resolution in live animals. Its optical transparency and genetic versatility allow noninvasive, real-time observations of vascular flow of nanoparticles and their interactions with cells throughout the body. As a consequence, this system enables the acquisition of quantitative data that are difficult to obtain in rodents. Until now, a few studies using the zebrafish model have only described semiquantitative results on key nanoparticle parameters. Here, a MACRO dedicated to automated quantitative methods is described for analyzing important parameters of nanoparticle behavior, such as circulation time and…

NANOCARRIERSEmbryo Nonmammalianmiceanimal structurescirculation timeCellNanoparticleLIPOSOMES02 engineering and technology010402 general chemistry01 natural sciencesSEQUENCEBiomaterialsMiceDELIVERYmedicineMedicine and Health SciencesAnimalsGeneral Materials ScienceZebrafishZebrafishbiologyChemistryMacrophagesEndothelial CellsOptical transparencyPLGAGeneral ChemistryTARGETING MACROPHAGES021001 nanoscience & nanotechnologybiology.organism_classificationzebrafishCANCER0104 chemical sciencesCell biologymacrophagesChemistrymedicine.anatomical_structureCell cultureembryonic structuresZebrafish embryoNanoparticlesCirculation timenanoparticlesNanocarriers0210 nano-technologyANTIBIOTICSBiotechnology
researchProduct

The zebrafish embryo as an in vivo model for screening nanoparticle-formulated lipophilic anti-tuberculosis compounds.

2021

ABSTRACT With the increasing emergence of drug-resistant Mycobacterium tuberculosis strains, new and effective antibiotics against tuberculosis (TB) are urgently needed. However, the high frequency of poorly water-soluble compounds among hits in high-throughput drug screening campaigns is a major obstacle in drug discovery. Moreover, in vivo testing using conventional animal TB models, such as mice, is time consuming and costly, and represents a major bottleneck in lead compound discovery and development. Here, we report the use of the zebrafish embryo TB model for evaluating the in vivo toxicity and efficacy of five poorly water-soluble nitronaphthofuran derivatives, which were recently id…

DrugIn vivo efficacyTuberculosismedicine.drug_classmedia_common.quotation_subjectAntibioticsAntitubercular AgentsNeuroscience (miscellaneous)Medicine (miscellaneous)Anti-tuberculosis drugsPharmacologyBiologyGeneral Biochemistry Genetics and Molecular BiologyMycobacterium tuberculosisMiceImmunology and Microbiology (miscellaneous)In vivoZebrafish as a Disease ModelmedicineAnimalsTuberculosisZebrafishmedia_commonIn vivo toxicityDrug discoveryMycobacterium tuberculosismedicine.diseasebiology.organism_classificationIn vitroZebrafish tuberculosis modelDrug developmentNanoparticlesResearch Article
researchProduct